000			01627 a2200421 4500
005			20250513191013.0
264		0	_c19991028
008			199910s 0 0 eng d
022			_a1043-0342
024	7		_a10.1089/10430349950017536 _2doi
040			_aNLM _beng _cNLM
100	1		_aMohajeri, M H
245	0	0	_aIntramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. _h[electronic resource]
260			_bHuman gene therapy _cJul 1999
300			_a1853-66 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAmyotrophic Lateral Sclerosis _xtherapy
650	0	4	_aAnimals
650	0	4	_aCell Transplantation
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aGenetic Therapy
650	0	4	_aGenetic Vectors
650	0	4	_aGlial Cell Line-Derived Neurotrophic Factor
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMotor Neurons _xphysiology
650	0	4	_aMuscle, Skeletal _xcytology
650	0	4	_aNerve Growth Factors
650	0	4	_aNerve Tissue Proteins _xgenetics
650	0	4	_aRetroviridae _xgenetics
650	0	4	_aTransduction, Genetic
650	0	4	_abeta-Galactosidase _xgenetics
700	1		_aFiglewicz, D A
700	1		_aBohn, M C
773	0		_tHuman gene therapy _gvol. 10 _gno. 11 _gp. 1853-66
856	4	0	_uhttps://doi.org/10.1089/10430349950017536 _zAvailable from publisher's website
999			_c10404647 _d10404647